ZEO ScientifiX’s cover photo
ZEO ScientifiX

ZEO ScientifiX

Biotechnology Research

Davie, Florida 420 followers

Extending Lifespans. Enriching Lives. Fueling Visions.

About us

Based in South Florida, ZEO ScientifiX™ is a publicly traded biotechnology company committed to the research, development and manufacture of new biologic medicine, with a focus on current and potential regenerative therapeutics. ZEO ScientifiX™ is the leading, fully integrated Biologic Medicine Company. Our mission is to transform regenerative medicine through the development of novel nano-technologies and to become the health care incubator for the next generation of biologic medicines.

Industry
Biotechnology Research
Company size
51-200 employees
Headquarters
Davie, Florida
Type
Public Company

Locations

Employees at ZEO ScientifiX

Updates

  • The ZEO Conference Series is just days away—but there’s still time to secure your spot!   • Experience exosomes first-hand and understand how they can enhance your practice, receive $500 OFF PPX™ Autologous Exosomes at the event • Learn from top regenerative medicine experts leading the future of patient care • Gain exclusive access to special pricing and product deals Extracellular vesicles are rapidly gaining momentum in medicine—now is the time to see their potential for yourself and learn how to integrate them into your practice. Register now: https://lnkd.in/gS-9aB2M

    • No alternative text description for this image
  • The Future of Medicine is Here – Are You Ready? Join us for the ZEO Conference Series this Friday, March 21st – available in-person and virtually! Discover the latest advancements in regenerative medicine using exosome biologics. This conference is designed for forward-thinking physicians looking to stay ahead in the field. - Regenerate your practice revenue with cutting-edge exosome technology! - Don’t miss this exclusive opportunity to connect with top experts and gain actionable insights. 🔗 Register now → https://lnkd.in/gS-9aB2M #RegenerativeMedicine #Exosomes #MedicalConference #Biotech #ZEOConferenceSeries

    This content isn’t available here

    Access this content and more in the LinkedIn app

  • Get ready for an incredible lineup at the ZEO Conference Series! Our agenda is packed with engaging, educational sessions—including a thought-provoking panel discussion featuring Joseph Banno, MD, Board-Certified Urologist and Carolyn DeLucia, MD, FACOG Board-Certified OB/GYN, moderated by our esteemed CMO, Dr. George Shapiro, MD, FACC ☆☆☆☆☆ Shapiro, MD, FACC ☆☆☆☆☆ , and CSTO, Peter A. Everts, PhD, FRSM. Don’t miss this opportunity to gain cutting-edge science learning, product knowledge, and clinical applications insights from the best in the field! Register Now: https://lnkd.in/gS-9aB2M

    • No alternative text description for this image
  • We kicked off 2025 with an incredible ZEO Conference Series on February 7th, setting the tone for a year of innovation and collaboration. Physicians and industry leaders engaged in deep discussions, exchanged cutting-edge insights, and built valuable connections—all in an environment designed to drive real change.   From thought-provoking panels to meaningful networking, the event was a testament to the power of shared knowledge. If you missed it, don’t worry—we’re keeping the momentum going!   📅 Mark your calendar for our next event: March 21st!   Join us as we continue to bring together leading minds for impactful conversations and opportunities that shape the future of healthcare. Register Now: https://lnkd.in/gc9UvZ5X

  • We are thrilled to announce that Peter A. Everts, PhD, FRSM., has joined ZEO ScientifiX as the Chief Scientific and Technology Officer, effective February 7, 2025. Dr. Everts brings a wealth of experience and deep expertise in regenerative medicine and ortho biological applications, developed over a distinguished career spanning clinical practice, research, and executive leadership. Before joining ZEO, Dr. Everts served as Chief Scientific Officer at EmCyte Corporation and Educational Program Director at Gulf Coast Biologics, where he contributed to cutting-edge advancements in autologous biological protocols for treating musculoskeletal and spine disorders, as well as aesthetic procedures. He has collaborated with leading universities across the globe, focusing on innovations that improve patient outcomes. His entrepreneurial journey includes co-founding the Da Vinci Clinic in the Netherlands, where he served as Chairman of the Board of Directors and specialized in hyperbaric medicine and advanced biological therapies for complex chronic wound care. Dr. Everts has also held key leadership roles at Avance Medical in Switzerland, overseeing regenerative medicine and cell therapies for European and Middle East markets. Dr. Everts holds a Ph.D. in Medicine from the University of Utrecht and continues to share his knowledge as an Adjunct Professor at the University of Queensland (Australia) and an International Professor at Max Planck University (Brazil). In December 2024, Everts received the Arnold Caplan “Lifetime Achievement Award” from the Regenerative Medicine Orthopaedic Society for his work in Orthobiologic Science. We are thrilled to have Dr. Everts on board and look forward to his leadership as we continue to advance innovation in regenerative therapies and beyond. #Leadership #Innovation #RegenerativeMedicine #WelcomeToZEO

    • No alternative text description for this image

Similar pages

Browse jobs